Liposomes Useful for Drug Delivery
AssigneeMerrimack Pharmaceuticals, Inc.
InventorsKeelung Hong, Daryl C. Drummond, Dmitri Kirpotin
Life of this patent
Estimating the term…
Abstract
The present invention provides liposome compositions containing substituted ammonium and/or polyanion, and optionally with a desired therapeutic or imaging entity. The present invention also provide methods of making the liposome compositions provided by the present invention.
Claims21
A pharmaceutical composition comprising a docetaxel prodrug liposome comprising sucrose octasulfate and an aminoacyl docetaxel pro-drug encapsulated within a unilamellar vesicle comprising sphingomyelin, cholesterol and a non-ionic PEG lipid derivative.
A composition of a liposome having an interior space, said composition comprising the liposome in an aqueous medium, wherein the interior space:
- 1) is aqueous, 2) is separated from the aqueous medium by a membrane comprised of one or more lipids, and 3) contains sucrose octasulfate polyanion in the form of an acid or a salt of a taxane selected from the group consisting of:
- docetaxel and 2′-(diethylamino)-ester aminoacyl docetaxel prodrug.
A docetaxel prodrug liposome composition comprising sucrose octasulfate and a 2′-(diethylamino)-ester aminoacyl docetaxel prodrug encapsulated within a liposome formed from one or more lipids, wherein at least about 90% of the docetaxel prodrug is encapsulated within the liposome.
A method of administering docetaxel to a patient in need thereof, the method comprising the step of parenterally administering to the patient a docetaxel prodrug liposome in a first aqueous medium at a pH of about 5.0-6.5, the docetaxel prodrug liposome comprising cholesterol and a phospholipid and encapsulating a 2′-(diethylamino)-ester aminoacyl docetaxel prodrug in a second aqueous medium encapsulated within the docetaxel prodrug liposome at a pH lower than the pH of the first aqueous medium, wherein at least a portion of the docetaxel pro-drug is converted to docetaxel outside the liposome after parenteral delivery of the docetaxel prodrug liposome to the patient.
Dependencies are inferred from the claim text.